These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38017515)

  • 21. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.
    Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP
    Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early antiviral treatment in outpatients with COVID-19 (FLARE): a structured summary of a study protocol for a randomised controlled trial.
    Brown LK; Freemantle N; Breuer J; Dehbi HM; Chowdhury K; Jones G; Ikeji F; Ndoutoumou A; Santhirakumar K; Longley N; Checkley AM; Standing JF; Lowe DM
    Trials; 2021 Mar; 22(1):193. PubMed ID: 33685502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Early Combination Therapy With Lianhuaqingwen and Arbidol in Moderate and Severe COVID-19 Patients: A Retrospective Cohort Study.
    Fang J; Li H; Du W; Yu P; Guan YY; Ma SY; Liu D; Chen W; Shi GC; Bian XL
    Front Pharmacol; 2020; 11():560209. PubMed ID: 33071781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials.
    Liang SB; Fang M; Liang CH; Lan HD; Shen C; Yan LJ; Hu XY; Han M; Robinson N; Liu JP
    Complement Ther Med; 2021 Aug; 60():102744. PubMed ID: 34091029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
    Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial.
    Lu H; Zhang G; Mao J; Chen X; Zhan Y; Lin L; Zhang T; Tang Y; Lin F; Zhu F; Lin Y; Zeng Y; Zhang K; Yuan W; Liang Z; Sun R; Huo L; Hu P; Lin Y; Zhuang X; Wei Z; Chen X; Yan W; Yan X; Mu L; Lin Z; Tu X; Tan H; Huang F; Hu Z; Li H; Li G; Fu H; Yang Z; Chen X; Wang FS; Zhong N
    EClinicalMedicine; 2024 May; 71():102582. PubMed ID: 38618202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
    Nasser A; Hull JT; Chaturvedi SA; Liranso T; Odebo O; Kosheleff AR; Fry N; Cutler AJ; Rubin J; Schwabe S; Childress A
    CNS Drugs; 2022 Aug; 36(8):897-915. PubMed ID: 35896943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective study of Pupingqinghua prescription versus Lianhuaqingwen in Chinese participants infected with SARS-CoV-2 Omicron variants.
    Dong Y; Zhai W; Fang B; Liu C; Yuan S; Wang Y; Song Q; Li H; Chen B; Cui D; Wang J; Wu Q; Zhou C; Zhou M; Li S; Zhuang X; Xu Q; Zheng Y; Wu Y; Zheng J; Cao M
    Front Pharmacol; 2022; 13():988524. PubMed ID: 36278166
    [No Abstract]   [Full Text] [Related]  

  • 30. Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.
    Adler UC; Adler MS; Hotta LM; Padula AEM; de Toledo Cesar A; Diniz JNM; Mestre CAA; Spiller KR; Soares L; de Freitas Santos H; Martinez EZ
    Trials; 2021 Feb; 22(1):109. PubMed ID: 33522951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.
    Chen X; Wu Y; Chen C; Gu Y; Zhu C; Wang S; Chen J; Zhang L; Lv L; Zhang G; Yuan Y; Chai Y; Zhu M; Wu C
    Acta Pharm Sin B; 2021 Jan; 11(1):222-236. PubMed ID: 33072499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial.
    Karimi M; Zarei A; Soleymani S; Jamalimoghadamsiahkali S; Asadi A; Shati M; Jafari M; Rezadoost H; Kordafshar G; Naghizadeh A; Mardi R; Namiranian P; Khamechi SP; Ansari N; Adel Mehraban MS; Aliakbarzadeh H; Khanavi M; Esmaealzadeh N; Moravveji A; Salahi M; Khoi M; Razzaghi R; Banafshe HR; Alizadeh M; Akhbari M; Atharizadeh M; Izadikhah A; Elsagh M; Hossein Zade Ghahnavieh M; Eghbalian F; Vanai A; Izadi H; Moravej SAA; Jazayeri SF; Bayat H; Emadi Koochak H; Zargaran A
    Phytother Res; 2021 Nov; 35(11):6295-6309. PubMed ID: 34606123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of herbal extracts to restore respiratory health and improve innate immunity in COVID-19 positive patients with mild to moderate severity: A structured summary of a study protocol for a randomised controlled trial.
    Rangnekar H; Patankar S; Suryawanshi K; Soni P
    Trials; 2020 Nov; 21(1):943. PubMed ID: 33225970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of vitamin D and magnesium supplementation on clinical symptoms and serum inflammatory and oxidative stress markers in patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Ramezani-Jolfaie N; Eftekhar E; Dadinasab M; Hesarooeyeh ZG; Pakdaman P; Razmpour F; Javedan G; Khayatian M; Azad MH; Davoodian P; Brahimi E; Rafati S; Nikoofal-Sahlabadi S; Mohammadi M
    Trials; 2023 Feb; 24(1):87. PubMed ID: 36747270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Guilingji Capsules () for Treating Mild-to-Moderate Cognitive Impairment: Study Protocol for A Randomized, Double-Blind, Positive-Controlled, Multicenter and Noninferiority Trial.
    Liu NY; Pei H; Liu MX; Liu LT; Fu CG; Li H; Chen KJ
    Chin J Integr Med; 2020 Aug; 26(8):577-582. PubMed ID: 32761337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.
    Shah MR; Fatima S; Khan SN; Ullah S; Himani G; Wan K; Lin T; Lau JYN; Liu Q; Lam DSC
    Front Med (Lausanne); 2022; 9():928468. PubMed ID: 35979216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of Pien Tze Huang capsules in patients with herpes zoster: A multicenter, randomized, double-blinded, and placebo-controlled trial.
    Wu W; Yang D; Sui D; Zhu M; Luo G; Yang Z; Wang Y; Luo H; Ling L; Zhang Z; Wu Y; Feng G; Li H
    Phytomedicine; 2024 May; 127():155453. PubMed ID: 38452692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
    Naggie S; Boulware DR; Lindsell CJ; Stewart TG; Gentile N; Collins S; McCarthy MW; Jayaweera D; Castro M; Sulkowski M; McTigue K; Thicklin F; Felker GM; Ginde AA; Bramante CT; Slandzicki AJ; Gabriel A; Shah NS; Lenert LA; Dunsmore SE; Adam SJ; DeLong A; Hanna G; Remaly A; Wilder R; Wilson S; Shenkman E; Hernandez AF;
    JAMA; 2022 Oct; 328(16):1595-1603. PubMed ID: 36269852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.